Proteasome subunit beta type-1

Description:

Description
  • Accession: P20618
  • Swissprot: PSB1_HUMAN
  • Organism: Homo sapiens
  • Gene: PSMB1
  • Target class: Enzyme

Drug Relations:

bortezomib
A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. Bioactivity details MOA
ixazomib
an oral proteasome inhibitor with antineoplastic activity; MLN2238 is the biologically active form of MLN9708 Bioactivity details MOA